Cell Dissociation Market Size, Share & Analysis Report, 2021-2027
The global Cell Dissociation market gathered revenue around USD 250 million in 2020 and market is set to grow USD 600 million by the end of 2027 and is estimated to expand at a modest CAGR of 16.1% during the prediction period 2021 to 2027. Growth of the market is driven mainly by increasing prevalence of cell based research, the increasing number of pharmaceutical and biotechnology companies.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Cell Dissociation market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Cell Dissociation market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
Emerging markets, such as China, India, and Brazil, are expected to offer significant growth opportunities for players operating in the cell dissociation market. These markets are expected to witness high growth in the coming years owing to the increasing R&D activities in the life sciences sector in these countries. For instance, pharmaceutical companies based in India are making significant investments in R&D to introduce new drugs into the market.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Cell Dissociation market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
North America accounted for the largest share of the cell dissociation market in 2020
Based on the region, the cell dissociation market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2020, North America accounted for the largest share of the cell dissociation market. The large share of North America can can primarily be attributed to the increasing research in pharmaceutical and biotechnology industries and the strong presence of major market players in this region.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Cell Dissociation Market are: Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Roche Diagnostics (Switzerland), Cytiva (a part of Danaher Corporation) (US), STEMCELL Technologies (Canada), Miltenyi Biotec (Germany), PromoCell GmbH (Germany), AcceGen(US), VitaCyte (US), Alstem (US), Biological Industries (Israel), Gemini Bio (US), Innovative Cell Technologies (US), Central Drug House (India), Worthington Biochemical Corporation (US), Capricorn Scientific (Germany), Abeomics (US), Genlantis (US), and Neuromics (US)
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
by Product
by Tissue
by Type
by End User
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Cell Dissociation Market, By Product
7.1. Cell Dissociation Market, by Product, 2021-2027
7.1.1. Enzymatic Dissociation Products
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Collagenase
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Trypsin
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Papain
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Elastase
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. DNase
7.1.6.1. Market Revenue and Forecast (2016-2027)
7.1.7. Hyaluronidase
7.1.7.1. Market Revenue and Forecast (2016-2027)
7.1.8. Other Enzymes
7.1.8.1. Market Revenue and Forecast (2016-2027)
7.1.9. Enzymatic Dissociation Products
7.1.9.1. Market Revenue and Forecast (2016-2027)
7.1.10. Instruments
7.1.10.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Cell Dissociation Market, By Tissue
8.1. Cell Dissociation Market, by Tissue, 2021-2027
8.1.1. Application 1
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Application 2
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Application 3
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Application 4
8.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Cell Dissociation Market, By Type
9.1. Cell Dissociation Market, by Type, 2021-2027
9.1.1. End User 1
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. End User 2
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. End User 3
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. End User 4
9.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Cell Dissociation Market, By End User
10.1. Cell Dissociation Market, by End User, 2021-2027
10.1.1. Capacitor 1
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Capacitor 2
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Capacitor 3
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Capacitor 4
10.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 11.Global Cell Dissociation Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2016-2027)
11.1.2. Market Revenue and Forecast, by Tissue (2016-2027)
11.1.3. Market Revenue and Forecast, by Type (2016-2027)
11.1.4. Market Revenue and Forecast, by End User (2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.1.5.2. Market Revenue and Forecast, by Tissue (2016-2027)
11.1.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.1.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.1.6.2. Market Revenue and Forecast, by Tissue (2016-2027)
11.1.6.3. Market Revenue and Forecast, by Type (2016-2027)
11.1.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.2. Market Revenue and Forecast, by Tissue (2016-2027)
11.2.3. Market Revenue and Forecast, by Type (2016-2027)
11.2.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.5.2. Market Revenue and Forecast, by Tissue (2016-2027)
11.2.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.2.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product(2016-2027)
11.2.6.2. Market Revenue and Forecast, by Tissue (2016-2027)
11.2.6.3. Market Revenue and Forecast, by Type (2016-2027)
11.2.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.7.2. Market Revenue and Forecast, by Tissue (2016-2027)
11.2.7.3. Market Revenue and Forecast, by Type (2016-2027)
11.2.7.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.8.2. Market Revenue and Forecast, by Tissue (2016-2027)
11.2.8.3. Market Revenue and Forecast, by Type (2016-2027)
11.2.8.4. Market Revenue and Forecast, by End User (2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.2. Market Revenue and Forecast, by Tissue (2016-2027)
11.3.3. Market Revenue and Forecast, by Type (2016-2027)
11.3.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.5.2. Market Revenue and Forecast, by Tissue (2016-2027)
11.3.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.3.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.6.2. Market Revenue and Forecast, by Tissue (2016-2027)
11.3.6.3. Market Revenue and Forecast, by Type (2016-2027)
11.3.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.7.2. Market Revenue and Forecast, by Tissue (2016-2027)
11.3.7.3. Market Revenue and Forecast, by Type (2016-2027)
11.3.7.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.8.2. Market Revenue and Forecast, by Tissue (2016-2027)
11.3.8.3. Market Revenue and Forecast, by Type (2016-2027)
11.3.8.4. Market Revenue and Forecast, by End User (2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.2. Market Revenue and Forecast, by Tissue (2016-2027)
11.4.3. Market Revenue and Forecast, by Type (2016-2027)
11.4.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.5.2. Market Revenue and Forecast, by Tissue (2016-2027)
11.4.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.4.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.6.2. Market Revenue and Forecast, by Tissue (2016-2027)
11.4.6.3. Market Revenue and Forecast, by Type (2016-2027)
11.4.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.7.2. Market Revenue and Forecast, by Tissue (2016-2027)
11.4.7.3. Market Revenue and Forecast, by Type (2016-2027)
11.4.7.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.8.2. Market Revenue and Forecast, by Tissue (2016-2027)
11.4.8.3. Market Revenue and Forecast, by Type (2016-2027)
11.4.8.4. Market Revenue and Forecast, by End User (2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.5.2. Market Revenue and Forecast, by Tissue (2016-2027)
11.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.5.5.2. Market Revenue and Forecast, by Tissue (2016-2027)
11.5.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.5.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.5.6.2. Market Revenue and Forecast, by Tissue (2016-2027)
11.5.6.3. Market Revenue and Forecast, by Type (2016-2027)
11.5.6.4. Market Revenue and Forecast, by End User (2016-2027)
Chapter 12. Company Profiles
12.1. Thermo Fisher Scientific
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Becton, Dickinson and Company
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Roche Diagnostics
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Cytiva
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. STEMCELL Technologies
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Miltenyi Biotec
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. PromoCell GmbH
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. AcceGen
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. VitaCyte
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Alstem
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers